Additionally, Kaplan–Meier survival analysis indicated that high expression of HOTAIRM1 in AML patients was associated with poor overall survival and recurrence-free survival (Fig. 2D). This evidence concerns the gene HOTAIRM1 and acute myeloid leukemia.